The Dry Eye Syndrome Treatment Market To Re-Invent The Growth Curve With A CAGR Of 7%

1
Dry Eye Syndrome Treatment Market
Report Id PMRREP32300 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
How Persistent Would Be The Dry Eye Syndrome
Treatment Market In The Upcoming Decade?

• Dry eye syndrome results in irritated and burning
  eyes due to lack of tear production and
  moisturization. Meibomian Gland Dysfunction has
  more prevalence among the geriatric population.
  The market consists of several products used in
  therapeutics, such as cyclosporine, topical
  corticosteroids, punctal plugs, omega
  supplements, and the especially popular
  artificial tears. Fast approval and launch of
  products used for dry eye treatment is expected
  to drive market growth in future.
• Several key market players are focused on
  collaborative product development, innovation,
  and expansion of product portfolio. For instance,
  in October 2020, Santen Pharmaceutical and Orbis
  International announced their long-term
  collaboration for ten years to contribute toward
  the increasing burden of eye diseases in low- and
  middle-income countries.
• Rapidly increasing number of eye care centers due
  to rising focus on primary eye care is expected
  to propel dry eye syndrome treatment market
  growth. Increasing number of LASIK surgeries,
  which is one of the major causes leading to dry
  eyes, is estimated to further drive market growth
  over the coming years.

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/32300
4
Key Takeaways from Market Study

• The artificial tears segment, by product, is
  estimated to generate the highest revenue share
  over the coming years, estimated to be valued at
  US 5 Bn by 2030, at an expected CAGR of over 7.
• COVID-19 has had a negative impact on the dry eye
  syndrome treatment market due to large-scale
  closures of manufacturing units and disruption in
  supply chain activities. Decreased hospital
  visits and focus on the pandemic further hurt
  market growth in 2020. However, long-term
  prospects look bright through 2030.
• Among the prescriptions, Rx is expected to
  dominate the market with more than 70 revenue
  share, with increasing number of eye care centers
  and rising treatment adoption rate for dry eyes.
• Among all distribution channels, retail
  pharmacies is the leading segment, followed by
  hospital pharmacies. Retail pharmacies are
  anticipated to grow at a CAGR of around 7 over
  the forecast period, owing to rise in the number
  of retail pharmacies and improving supply chain
  activities.
• North America and Europe are leading regions in
  the global dry eye syndrome treatment market,
  with a revenue share of around 70.
• The market in the U.S. and Germany is projected
  to expand at a CAGR of around 7 through 2030.
• The market in Japan is slated to progress at a
  steady CAGR of over 6 over the next ten years.
• Rising diagnosis and treatment adoption has led
  to increasing product innovation and development,
  contributing to market. Developing and
  under-developed countries with high prevalence of
  dry eye syndrome and lower product adoption will
  create several opportunities for leading market
  players, says a Persistence Market Research
  analyst.

Access Full Report _at_ https//www.persistencemarket
research.com/checkout/32300
5
(No Transcript)